CMI_LatestReportOrientedBlogs

  The botanical and plant derived drugs are obtained from medicinal plants, which contain algae, microscopic fungi or any vegetable material. They are used for treatment of varied health conditions such as for example cardiovascular diseases, respiratory disease, central nervous system disorders, and infectious diseases. High threat of unwanted effects caused as a result of usage of synthetic drugs such as for example hypersensitive reaction and gastrointestinal upsets, drugs recalls, and high cost of specialty drugs are propelling the adoption of the botanical and plant derived drugs. The major classes of botanical and plant derived drugs are Tarpenes and Ergot Alkaloids, Steroids, Vinca Alkaloids, Glycosides, and Morphine Alkaloids. Furthermore, increasing prevalence of chronic disease and inexpensive of botanical drugs are likely to foster the growth of botanical and plant derived drugs market.   The Botanical and Plant Derived Drugs Market is estimated to be valued at US$ 30.1 Bn

  Increasing numbers of people suffering from health conditions related to modern environmental factors are turning to botanical and plant-derived medicines to treat their illnesses, which is expected to propel growth of the Botanical and Plant Derived Drugs Market . These alternative medicines are generally made from natural ingredients obtained from plants, herbs, and trees. A number of countries have taken steps to regulate the production and sales of botanical and plant-derived drugs, while others are planning to create national level standards for natural remedies. In the United States, government regulations regarding botanical drug manufacturing are more restrictive than those of other countries. In addition, the Food and Drug Administration (FDA) has placed several conditions on the marketing of such drugs, especially vitamins. The Botanical and Plant Derived Drugs Market is expected to witness significant growth in the near future. By adopting an economically an